RPL21P88

Across TCGA pan-cancer cohorts, RPL21P88 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RPL21P88’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where RPL21P88 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL21P88 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

BLCA, PRAD, and KIRC are the cancer types where RPL21P88 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL21P88 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	All	+0.042	.036	2	view →
PRAD	All	All	+0.037	.031	2	view →
KIRC	Female	All	+0.074	.024	1	view →
KICH	All	All	−0.030	.046	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RPL21P88–BLCA

Open the BLCA breakdown →